Newsletter
Join the Community
Subscribe to our newsletter for the latest news and updates
Four vendor demos in one month, and not one sales rep could answer 'what does the AI actually do?' Here is a structured framework for evaluating insurance AI tools.
2026/05/09
Last reviewed 2026/06/06
Four vendor demos in four weeks. Each sales engineer opens with a slide about "AI-powered" capabilities. Each demo is polished, the best-case scenario, the most favorable data. When you ask "what specifically does the AI do, and how do you measure whether it works?" the room gets slightly uncomfortable. One rep mentions "proprietary machine learning." Another says "advanced natural language processing." A third pivots back to the product roadmap. Not one of them answers the question directly.
This is the current state of insurance AI vendor evaluations for most agencies and carriers. The "AI" label has become a marketing default rather than a technical description. Some of the tools labeled AI are genuinely using machine learning models that provide measurable value. Others are applying fixed business rules through a modern interface and calling it AI. Most are somewhere in between. Your job as the evaluator is to tell them apart — and to build a decision process that does not rely on taking vendor claims at face value.
What follows is the methodology we use at InsurAItools to evaluate and compare tools. We are making it explicit here because we believe evaluators who understand our framework will be better equipped to conduct their own assessments.
The standard evaluation process for insurance software tools breaks down in a specific and predictable way. An agency or carrier identifies a need, puts out an RFP or schedules vendor demos, watches a set of polished presentations, scores them on a feature checklist, and selects a winner. The feature checklist approach has two fatal flaws.
First, feature lists describe capabilities, not workflows. A tool may have a feature called "automated document processing" that, in practice, requires a staff member to review and correct 40% of its outputs before they are usable. That feature is technically present, but its real-world value is substantially less than the feature name implies. Demos are designed to show the 60% that works well and skip past the 40% that does not.
Second, the comparison happens across the vendor's framing, not yours. Every vendor presents their strengths. The evaluation should be structured around your specific workflows and the specific failures you are trying to prevent — not the features the vendor wants to show you.
The third problem is hidden costs. Most insurance AI tools do not publish pricing. The comparison you can make in a demo is between demos, not between total cost of ownership. A tool that appears less expensive based on the license fee may cost twice as much when implementation, training, integration, and ongoing support are factored in. See our total cost of ownership glossary entry for the full cost framework.
A structured evaluation methodology forces the comparison onto your terms, not the vendor's, and surfaces the information that demos are designed to obscure.
Every evaluation should start with a specific, written problem statement. Not "we want an AI tool for claims" but "we are processing 800 FNOL submissions per month, our average cycle time from FNOL to first payment is 18 days, and we want to reduce that to 10 days without adding staff." Not "we want to improve underwriting" but "our underwriters are reviewing 240 submissions per week and binding 90; the other 150 are being declined or pended after significant review time, and we believe pre-screening could eliminate 60% of those without sacrificing quality."
The problem statement disciplines the evaluation in three ways. It tells you which metrics to ask for from vendors (cycle time reduction, pre-screening accuracy). It sets the minimum bar a tool needs to clear to be worth buying. And it gives you something specific to test in a pilot.
Evaluations without a specific problem statement drift toward feature comparisons, and feature comparisons tend to favor the vendor with the most features rather than the vendor who solves your problem. There is no correlation between feature count and fit for a specific problem.
Document your current state metrics before you start evaluating. If you do not know your current cycle time, containment rate, or straight-through processing rate, get those numbers first. You cannot measure improvement against a baseline you do not have.
This is the most important technical distinction in any insurance tool evaluation, and it is the one vendors most often blur.
Rules-based automation executes predefined logic. If policy number field is populated and premium is greater than $X and no open claims in the last 18 months, route to auto-bind queue. Rules-based automation is deterministic — given the same inputs, it produces the same output every time. It is not adaptive. If a new pattern emerges that the rules did not anticipate, it does not adjust.
Machine learning-based AI learns statistical patterns from training data and applies those patterns to new inputs. It is probabilistic — given the same inputs, it produces a confidence-weighted output. It can identify patterns that no human explicitly programmed as rules. It can improve over time with additional training data. And it can be wrong in ways that rules-based automation is not — a rules-based system fails predictably (the rule fires or it does not); a model fails probabilistically (the model assigns high confidence to an incorrect prediction).
Both categories can be valuable. Many effective automation tools in insurance are rules-based. The issue is when ML-based claims are made for rules-based systems — because the evaluation criteria differ. ML systems need to be evaluated on predictive accuracy, model drift, explainability, and training data quality. Rules-based systems need to be evaluated on coverage, exception handling, and maintenance overhead.
How to tell them apart:
At InsurAItools, we document this distinction explicitly in every tool review. Tools that use genuine ML are labeled accordingly; tools that use rules-based automation marketed as AI are described accurately. See our reviews of Gradient AI and Planck for examples of how we document this in underwriting platforms, and Shift Technology for a claims fraud detection tool that makes the distinction clear.
After you have established what problem you are solving and whether the tool is genuinely using AI, the next step is to understand what the vendor actually measures and what real-world performance data looks like.
The right questions here are specific and require specific answers:
"What is the straight-through processing rate your customers achieve for [relevant claim or transaction type]?" Not "what is your average STP rate" but what percentage of the specific transaction type you care about processes without human intervention.
"What is the measured false positive rate in [fraud detection / triage / risk scoring]?" False positives matter because they create work for staff who have to review and clear flagged cases that are not actually problematic. A fraud detection tool that flags 15% of claims as suspicious when 2% of them are actually fraudulent is producing a lot of unnecessary work.
"What is the cycle time reduction your customers have measured, relative to what baseline?" Cycle time claims without a baseline are meaningless. Vendors should be able to say: "Customer A had an average cycle time of 22 days before implementation; after 90 days of production use, they were at 14 days."
"How do you measure model accuracy over time, and what happens when the model drifts?" Model drift is the gradual degradation of model performance as the real-world data distribution diverges from the training data. This is a real problem in insurance models, particularly after market disruptions. Ask how the vendor detects drift and what the remediation process is.
"How many customers have churned in the last 24 months, and why?" This question usually gets a redirect. Push for an answer. Churn patterns are the most honest available signal about where a product fails in production.
If a vendor cannot provide specific metric answers with customer attribution, treat their aggregate performance claims with significant skepticism. Marketing claims about "up to 40% reduction in processing time" are close to meaningless without a customer reference to call.
Insurance tools handle sensitive personal information — policyholder names, dates of birth, Social Security numbers, financial information, health information in some cases. Before any other technical evaluation, confirm the security baseline.
SOC 2 Type II is the standard for cloud-based software vendors that handle sensitive data. A SOC 2 Type II report covers the design and operating effectiveness of security controls over a 12-month period. A Type I report covers design only, not effectiveness — Type I is a much weaker attestation. Ask for the most recent Type II report, not just confirmation that SOC 2 certification exists.
HITRUST CSF is a more comprehensive framework that incorporates HIPAA and several other regulatory frameworks. It is increasingly required by larger carriers and MGAs as a vendor qualification criterion. If your client base includes health-adjacent lines (group benefits, workers comp with medical management), HITRUST becomes more important.
Subprocessor disclosure matters because most cloud software vendors use subprocessors — third-party services like AWS, Google Cloud, or specialized ML platforms — that may themselves access or store your data. Ask for a complete subprocessor list and understand what data each subprocessor handles. This is particularly important if you have state-specific data residency requirements.
Data handling in AI training is a newer concern that many evaluators overlook. If a vendor trains its AI model on customer data — which improves the model but means your policyholder data is part of a shared training corpus — you need to understand the data anonymization practices, the contractual restrictions on that use, and whether you can opt out. Review the contract's data processing agreement, not just the main service agreement.
Every insurance AI tool needs to fit into an existing technology stack: your AMS, your carrier portals, your document management system, your claims platform. The integration question is frequently underestimated in evaluations and overestimated in vendor pitches.
Ask specifically:
"Does the tool offer an API, and what does the API documentation look like?" Ask to see the actual API documentation before you commit, not a summary. The documentation tells you how mature the integration capability is.
"What pre-built connectors are available for [your AMS or policy system]?" Pre-built connectors save implementation time but may not be maintained at the same version as the core product. Ask when the connector for your specific AMS was last updated.
"What is the typical implementation timeline for customers with our stack?" Get a reference case that matches your specific system environment. An implementation that takes 6 weeks for an agency on one AMS may take 16 weeks for an agency on a different AMS because the connector work needs to be custom-built.
"Who owns the integration if something breaks?" When a data sync between your AMS and the AI tool fails, who diagnoses it and who fixes it? The answer tells you about support model maturity. Vendors who say "it's covered under our support agreement" are better than vendors who say "you'd need to engage your AMS vendor."
The integration complexity is also a major driver of total cost of ownership. A lower-priced tool that requires 200 hours of custom integration work may cost more in total than a higher-priced tool with a certified pre-built connector.
Reference calls are the most valuable and least well-used part of a vendor evaluation. Most evaluators ask references whether they are satisfied with the product. Satisfied customers are the only ones vendors provide as references, so the answer is almost always yes.
Better questions for reference calls:
"What broke in the first 90 days?" Something always breaks. This question is calibrating for problems, which the reference is more likely to answer honestly than a direct "are you happy" question. The nature of what broke tells you about the vendor's failure modes.
"Describe a moment where you were frustrated with the vendor's support response." Not "are you happy with support" but a specific incident. The reference's answer tells you both about support quality and about the kinds of problems that recur.
"What would you negotiate differently if you were signing the contract today?" This surfaces the things the reference learned after signing that they wish they had known before. Contract terms, implementation scope definitions, data migration commitments — these tend to come up.
"What does your staff actually use versus what they were supposed to use?" The gap between what was implemented and what is actually in daily use is a proxy for adoption success. A tool that staff have found workarounds for has an adoption problem that you will inherit.
"Would you buy it again if you were starting fresh today?" The most direct retention signal. Follow up with "what has changed since you bought it" to get current-state perspective.
Ask the vendor to provide four to six references, including at least one that is comparable to your agency or operation in size and complexity. If they can only provide two or three references, or all references are significantly larger or different from your situation, note that.
License fee comparisons are not cost comparisons. The true cost of an insurance AI tool includes:
License fee — typically annual, often per-seat or per-transaction. For quote-based pricing, request the vendor's TCO estimate in writing with a signed customer reference confirming the estimate is in a realistic range.
Implementation cost — internal staff time plus any external consultant or professional services fees. For integrations that require custom development, this can equal or exceed the first year's license fee.
Training cost — staff training, which has both a direct cost (training time, training materials) and an indirect cost (reduced productivity during the learning period). For an operation with 15 staff members, training costs are non-trivial.
Ongoing support and maintenance — annual support fees, version upgrade costs, and the cost of any ongoing configuration management.
Opportunity cost of migration — for tools that replace an existing system, the cost of running dual systems during a transition, the productivity loss during migration, and the risk premium on data integrity.
Exit cost — the cost of leaving the vendor if the tool does not work. Data portability limitations, contract termination fees, and re-implementation costs for a replacement tool.
Build the model across a 3-year horizon. Many insurance AI tools have first-year costs that are front-loaded with implementation; the true cost picture looks different in years two and three.
See our total cost of ownership framework for a full template.
A well-structured pilot is the most reliable signal available about whether a tool will work in your environment. A poorly structured pilot produces false confidence.
A meaningful pilot has four characteristics:
Real production data, not demo data. The vendor's demo data is curated to show the tool at its best. Your production data includes the edge cases, the legacy records, the incomplete information, and the unusual scenarios that a demo never shows. The tool needs to work on your data, not the vendor's examples.
A defined success metric tied to your problem statement from Step 1. The pilot either hits the metric or it does not. If your target is 40% straight-through processing on standard auto claims and the pilot produces 18%, that is a decision-relevant data point, not a reason to keep running the pilot indefinitely hoping performance improves.
A defined duration and review point. 30 to 60 days is typical. The duration should be long enough to get past the initial configuration phase and into steady-state performance. Shorter pilots sometimes catch only the honeymoon period.
Staff participation, not just executive observation. The people who will use the tool daily need to interact with it during the pilot. Executive evaluations miss the operational friction that staff discover immediately — the extra clicks, the unclear outputs, the cases the model handles badly.
Document the pilot results specifically: what you tested, what the metrics showed, what problems emerged, how the vendor responded to problems during the pilot. This documentation is the basis for the final decision and for holding the vendor to commitments post-contract.
At InsurAItools, every tool review applies a consistent scoring framework across five dimensions:
Functional accuracy (30%) — does the tool do what it claims, at the performance level claimed? This includes AI/ML claim verification, metrics validation, and edge case testing.
Integration and implementation (20%) — how complex is the integration, what is the realistic implementation timeline, and what does the support model look like?
Security and compliance (20%) — SOC 2 Type II, data handling practices, subprocessor transparency, and relevant regulatory compliance.
User experience and adoption (15%) — staff adoption rate, training quality, UI clarity, and workflow friction in production use.
Total cost and value (15%) — 3-year TCO model relative to the specific problem being solved and the alternatives available.
We publish our reasoning for each dimension score, not just the composite score. A tool that scores well on functional accuracy but poorly on integration complexity should be evaluated differently than a tool that scores well on integration but is mediocre on accuracy. The composite score is a starting point; the dimension breakdown is where the useful information lives.
See our tool comparisons — including EZLynx vs. Applied Epic, Gradient AI vs. Planck, and Cytora vs. Federato — to see this framework applied to specific tool pairs.
For broader context on where the industry is heading, our insurance-ai-trends-2026 post covers the landscape changes that affect which evaluation criteria are becoming more important.
InsurAItools is editorially independent. We do not accept payment for placement or rankings. Our evaluation methodology is described at /methodology.
Editorial verdict: The eight steps in this guide will not make a vendor evaluation fast. They will make it honest. The goal is not to find the most impressive demo — it is to find the tool that solves your specific problem at a cost you can justify, without discovering a year into the contract that the AI capabilities were mostly marketing. The vendors who push back hardest against specific, documented evaluation criteria are usually the ones with the most to hide. The vendors who welcome detailed pilots, provide real reference contacts, and publish clear data handling policies are signaling something about how they operate in production.
Ask the vendor to describe the specific model or algorithm, what data it was trained on, how it handles edge cases, and what the measured accuracy is on a held-out test set. Genuine ML-based systems can answer these questions specifically. If the answer is vague — "proprietary technology" or "sophisticated automation" — you may be looking at rules-based automation marketed as AI. Both can be useful, but the claims are different and the evaluation criteria should be too. A rules-based system should be evaluated on rule coverage and maintenance overhead; an ML system should be evaluated on predictive accuracy, model drift, and training data quality.
SOC 2 Type II is the baseline for any vendor that will handle policyholder data. HITRUST CSF is a stronger standard and is increasingly required by carriers and MGAs. If the vendor handles payment data, PCI DSS applies. Ask for the most recent audit report, not just a badge on the website — audit reports expire, and badge displays are often not updated after an audit lapses. Also ask specifically about the scope of the SOC 2 audit: some vendors audit only a subset of their systems, and the scope limitations section of the report will tell you what is and is not covered.
Build a normalized cost model using the proxy inputs you can get: the minimum contract term, any disclosed per-user or per-transaction fees, and comparable deals from reference customers if they are willing to share. Request a total cost of ownership estimate from the vendor in writing, including implementation and training costs. If the vendor refuses to provide any pricing indication before a demo, that is useful information about how they operate — expect the same opacity in contract negotiations. Also use the peer community: agent forums, broker associations, and independent technology consultants who have seen recent deals can give you a realistic range even when vendors will not.